Deep Vein Arterialization for No-Option CLTI Patients: Technology and Clinical Program Update
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - Medtronic; Abbott; Terumo Medical Corporation; Boston Scientific Corporation; Phillips
- Equity/Stock(s)/Options - ANT; Inquis